Central Pharma Ltd has disclosed its unaudited earnings report for the third Quarter (January ’23-March’23).

The report was released after reviewing and approving the company's board meeting held on Sunday (April 30).

As per the disclosure, (January ’23-March’23) its earnings per share (EPS) has been lost Tk 0.05 for against one year at the same time earnings per share (EPS) was lost Tk 0.08.

Last 9 months (July’22- March’23) has been lost Tk 0.19 for against one year earnings per share (EPS)was lost Tk 0.26.

31 March 2023 it’s Net Asset Value (NAV) has been Tk 5.77

nj